Rockville, MD , Sept. 10, 2024 (GLOBE NEWSWIRE) -- The global Gingival Recession Treatment Market is projected to reach US$ 5.38 billion by the end of 2034, up from US$ 3.18 billion in 2024, according to the latest industry analysis by Fact.MR.
Cosmetic dentistry is gaining popularity as individuals are becoming more interested in aesthetic enhancements. As more individuals seek out treatments for healthier smiles, this trend is having a favorable effect on the growth of the gingival treatment market. A smile enhances a person’s overall appearance, which is why gingival recession treatments are in more demand since they efficiently restore the gum lines while also improving appearance overall. Gingival therapy demand is increasingly being driven by aesthetic concerns among women.
North America is projected to hold the leading position throughout the forecast period due to the increasing prevalence of periodontal disorders and the well-established healthcare sector. Western Europe is expected to take second place with a significant share, owing to rising cases among the elderly and the availability of strong reimbursement policies for dental procedures managed by the Conformité Européenne marking.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10299
Key Takeaways from the Market Study:
- The global gingival recession treatment market is forecasted to expand at a CAGR of 5.4% from 2024 to 2034.
- North America is set to account for 41% of the global market share in 2024.
- The United States is estimated to account for 6.2% market share in the North American region in 2024.
- The market in India is forecasted to expand at a CAGR of 9% from 2024 to 2034.
- The market in Japan is analyzed to generate revenue worth US$ 167.3 million by the end of 2034.
- Based on end users, dental clinics are projected to generate revenue worth US$ 2.96 billion by the end of 2034.
- In Western Europe, demand for gingival recession treatment is projected to reach a market value of US$ 1.01 billion by 2034.
- By treatment, revenue from soft tissue grafts is forecasted to reach US$ 2.11 billion by 2034.
“Use of growth factors and biomaterials for effective tissue regeneration is increasing worldwide. Availability of specialized equipment and professionals is driving the adoption of gingival recession treatment in dental clinics,” says a Fact.MR analyst.
Leading Players Driving Innovation in the Gingival Recession Treatment Market: Straumann Group; Dentsply Sirona; Geistlich Pharma; Zimmer Biomet Dental; Colgate-Palmolive; 3M Oral Care; Ivoclar Vivadent; Hu-Friedy; Kuraray Noritake Dental; GC Corporation; BioChange; Grin.
Soft Tissue Graft Treatment Gaining Prominence:
Demand for soft tissue grafts exceeds that for other gingival recession treatments because they effectively repair gum lines and stop the progression of the condition. Known for their ability to create healthy, connected gingiva, free soft tissue techniques facilitate root-covering renewal and reduce recession. This makes them a preferred choice for those seeking long-term, sustainable results. Rising preference for minimally invasive procedures, which promise less pain and faster recovery, is driving the increasing popularity of free soft tissue graft treatments.
Gingival Recession Treatment Industry News:
- In April 2023, Grin introduced new products during the AAO Annual Session that improve record keeping, practice management, and communication. Grin, a comprehensive virtual care platform that connects practitioners and patients, announced the launch of many new products during the American Association of Orthodontics Annual Meeting in Chicago.
- In September 2022, BioChange, an Israeli business that has developed a breakthrough tissue regeneration technology, successfully treated canine periodontitis (Gum Recession Disease). The usage of BioChange's ReGum resulted in a 100% improvement over the standard-of-care treatment regimen, with considerable regeneration of periodontal tissue. Dr. Ana Nemec, Jerzy Pawel Gawor, and Peter Strøm reported their statistically significant findings in Frontiers in Veterinary Science.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=10299
More Valuable Insights on Offer:
Fact.MR, in its new offering, presents an unbiased analysis of the gingival recession treatment market, presenting historical demand data (2019 to 2023) and forecast statistics for 2024 to 2034.
The study divulges essential insights into the market based on treatment (free soft tissue grafts, guided tissue regeneration, pedicle soft tissue flaps, laser therapy, growth factors & biomaterials, removable gingival veneers), age group (pediatric, adult, geriatric), indication (anatomical, plaque-induced periodontics, trauma, iatrogenic factors, smoking & tobacco consumption, aging, hormonal changes, gingival biotype), and end user (hospitals, dental clinics), across seven major regions of the world (North America, Western Europe, Eastern Europe, East Asia, Latin America, South Asia & Pacific, and MEA).
Segmentation of Gingival Recession Treatment Market Research:
- By Treatment :
- Free Soft Tissue Grafts
- Epithelial Grafts
- Subepithelial CT Grafts
- Guided Tissue Regeneration (GTR)
- Pedicle Soft Tissue Flaps
- Rotational Flaps
- Advancement Flaps
- Laser Therapy
- Growth Factors & Biomaterials
- Removable Gingival Veneers
- Free Soft Tissue Grafts
- By Age Group :
- Pediatric
- Adult
- Geriatric
- By Indication :
- Anatomical
- Plaque-Induced Periodontics
- Trauma
- Iatrogenic Factors
- Smoking & Tobacco Consumption
- Aging
- Hormonal Changes
- Gingival Biotype
- By End User :
- Hospitals
- Dental Clinics
Checkout More Related Studies Published by Fact.MR Research:
The global psychotic disorder treatment market accounts for US$ 13.6 billion and is projected to surge past a valuation of US$ 24.5 billion by the end of 2032.
The global alexandrite laser treatment market size is calculated at US$ 48.7 million for 2024 and is forecasted to reach US$ 83.2 million by the end of 2034, advancing at a CAGR of 5.5% between 2024 and 2034.
Worldwide demand for Lewy body dementia treatment accounts for a market value of US$ 4.7 billion in 2023. Across the study period (2023 to 2033), the global Lewy body dementia treatment market size is predicted to expand steadily at 6% CAGR and reach US$ 8.45 billion by the end of 2033.
Antibiotic-Associated Diarrhea Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2018 to 2028
Bell’s Palsy Treatment Market Based on Drug Class (Corticosteroids, Anticonvulsants, Antibacterial, Antivirals), Based on distribution channel (Hospital, Retail, Drug Stores, Online) - Global Insights to 2028
Factor XIII Deficiency Treatment Market Based on treatment(fresh frozen plasma and pharmaceuticals product)- Global Review 2018 to 2028
About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning. With its unwavering dedication to providing reliable market intelligence, FACT.MR continues to assist companies in navigating dynamic market challenges with confidence and achieving long-term success. With a global presence and a team of experienced analysts, FACT.MR ensures its clients receive actionable insights to capitalize on emerging opportunities and stay ahead in the competitive landscape.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team: sales@factmr.com
Follow Us: LinkedIn | Twitter | Blog
